Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia.
Chang-Hee SuhYoonhee LeeSang-Bae YooHolly A QuasnyAldo Amador Navarro RojasAnne HammerYeong-Wook SongYoung Mo KangChul-Soo ChoWon ParkSeung Ki KwokSeung-Geun LeeWon Tae ChungSang-Cheol BaePublished in: International journal of rheumatic diseases (2023)
Belimumab was efficacious for the treatment of SLE and well tolerated among the South Korean subgroup of patients from the NEA study.